<VariationArchive RecordType="classified" VariationID="2498196" VariationName="NM_000397.4(CYBB):c.766del (p.Glu256fs)" VariationType="Deletion" Accession="VCV002498196" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-26" DateCreated="2023-04-15" MostRecentSubmission="2023-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2473274" VariationID="2498196">
      <GeneList>
        <Gene Symbol="CYBB" FullName="cytochrome b-245 beta chain" GeneID="1536" HGNC_ID="HGNC:2578" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.1-11.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37780059" stop="37813461" display_start="37780059" display_stop="37813461" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="37639269" stop="37672713" display_start="37639269" display_stop="37672713" Strand="+" />
          </Location>
          <OMIM>300481</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CYBB">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CYBB">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000397.4(CYBB):c.766del (p.Glu256fs)</Name>
      <CanonicalSPDI>NC_000023.11:37799044:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37799045" stop="37799045" display_start="37799045" display_stop="37799045" variantLength="1" positionVCF="37799044" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="37658298" stop="37658298" display_start="37658298" display_stop="37658298" variantLength="1" positionVCF="37658297" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>E256fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000397.4" sequenceAccession="NM_000397" sequenceVersion="4" change="c.766del" MANESelect="true">
            <Expression>NM_000397.4:c.766del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000388.2" sequenceAccession="NP_000388" sequenceVersion="2" change="p.Glu256fs">
            <Expression>NP_000388.2:p.Glu256fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.37658299del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.37658299del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.37799046del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.37799046del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009065.1" sequenceAccession="NG_009065" sequenceVersion="1" change="g.24026del">
            <Expression>NG_009065.1:g.24026del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_53" sequenceAccession="LRG_53">
            <Expression>LRG_53:g.24026del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_53t1" sequenceAccession="LRG_53t1">
            <Expression>LRG_53t1:c.766del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_53p1" sequenceAccession="LRG_53p1" change="p.Glu256Asnfs">
            <Expression>LRG_53p1:p.Glu256Asnfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <FunctionalConsequence Value="loss_of_function_variant">
        <XRef ID="SO:0002054" DB="Sequence Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000397.4(CYBB):c.766del (p.Glu256fs) AND Granulomatous disease, chronic, X-linked" Accession="RCV003219212" Version="1">
        <ClassifiedConditionList TraitSetID="3042">
          <ClassifiedCondition DB="MedGen" ID="C1844376">Granulomatous disease, chronic, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-04-15" MostRecentSubmission="2023-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general" Abbrev="ACMG, 2015">
          <ID Source="PubMed">25741868</ID>
          <ID Source="pmc">4544753</ID>
          <ID Source="DOI">10.1038/gim.2015.30</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="BookShelf">99496</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30716179</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3042" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1398" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CYTOCHROME b-NEGATIVE GRANULOMATOUS DISEASE, CHRONIC, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, SOMATIC MOSAIC</ElementValue>
                <XRef Type="Allelic variant" ID="300481.0021" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Granulomatous disease, chronic, X-linked</ElementValue>
                <XRef ID="MONDO:0010600" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CGDX</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">X-CGD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CGD</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder of phagocytes (neutrophils, monocytes, macrophages, and eosinophils) resulting from impaired killing of bacteria and fungi. CGD is characterized by severe recurrent bacterial and fungal infections and dysregulated inflammatory responses resulting in granuloma formation and other inflammatory disorders such as colitis. Infections typically involve the lung (pneumonia), lymph nodes (lymphadenitis), liver (abscess), bone (osteomyelitis), and skin (abscesses or cellulitis). Granulomas typically involve the genitourinary system (bladder) and gastrointestinal tract (often the pylorus initially, and later the esophagus, jejunum, ileum, cecum, rectum, and perirectal area). Some males with X-linked CGD have McLeod neuroacanthocytosis syndrome as the result of a contiguous gene deletion. While CGD may present anytime from infancy to late adulthood, the vast majority of affected individuals are diagnosed before age five years. Use of antimicrobial prophylaxis and therapy has greatly improved overall survival.</Attribute>
                <XRef ID="NBK99496" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22876374</ID>
                <ID Source="BookShelf">NBK99496</ID>
              </Citation>
              <XRef ID="379" DB="Orphanet" />
              <XRef ID="C1844376" DB="MedGen" />
              <XRef ID="MONDO:0010600" DB="MONDO" />
              <XRef Type="MIM" ID="306400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7259443" SubmissionDate="2023-04-11" DateLastUpdated="2023-04-15" DateCreated="2023-04-15">
        <ClinVarSubmissionID localKey="SUB13027968" submittedAssembly="GRCh37" title="SUB13027968" />
        <ClinVarAccession Accession="SCV003852764" DateUpdated="2023-04-15" DateCreated="2023-04-15" Type="SCV" Version="1" SubmitterName="Unidad de Medicina Traslacional, Hospital de Ninos Ricardo Gutierrez" OrgID="508785" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="BookShelf">99496</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">30716179</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
          <Comment>The variant c.766del (p.Glu256Asnfs*13) results in a frameshift with the creation of a premature stop codon. It is expected to result in a truncated or an absent protein due to nonsense-mediated decay. This variant is not present in population databases (gnomAD) and has not been reported in the literature in association with CYBB-related disorders. Loss-of-function variants in CYBB are a well known mechanism of disease (PMID: 30716179; PMID: 9585602). Clinical laboratory testing of the patient sample by flow cytometry, which measures the oxidation of dihydrorhodamine 123 to rhodamine 123 in phorbol myrisate acetate (PMA)-stimulated neutrophils, showed a profound impairment of phagocyte oxidase activity. Based on the evidence outlined above, the variant is classified as pathogenic according to ACMG criteria (PVS1_VeryStrong, PM2_supporting, PS3_supporting) (PMID: 25741868).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0011955" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002240" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0100806" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002719" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001874" />
              </Trait>
            </TraitSet>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>not applicable</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not applicable</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">Absent NADPH oxidase activity through the dihydrorhodamine (DHR) flow cytometry assay.</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBB">
              <Name>cytochrome b-245 beta chain</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000397.4:exon 7</GeneLocation>
          </Location>
          <FunctionalConsequence Value="loss_of_function_variant">
            <XRef DB="Sequence Ontology" ID="SO:0002054" URL="http://www.sequenceontology.org/browser/current_svn/term/SO:0002054" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000397.4:c.766del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="306400" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13027968</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7259443" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002240" MappingRef="HP">
        <MedGen CUI="C0019209" Name="Hepatomegaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7259443" TraitType="Disease" MappingType="XRef" MappingValue="306400" MappingRef="OMIM">
        <MedGen CUI="C1844376" Name="Granulomatous disease, chronic, X-linked" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7259443" TraitType="Finding" MappingType="XRef" MappingValue="HP:0100806" MappingRef="HP">
        <MedGen CUI="C0036690" Name="Sepsis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7259443" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002719" MappingRef="HP">
        <MedGen CUI="C0239998" Name="Recurrent infections" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7259443" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001874" MappingRef="HP">
        <MedGen CUI="C0427515" Name="Abnormality of neutrophils" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7259443" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011955" MappingRef="HP">
        <MedGen CUI="C4023110" Name="Hepatic granulomatosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

